News
- June 20, 2025
- Ginger Vieira
Vertex Shares Update on VX-880 Clinical Trial at ADA Scientific Sessions
News
- June 10, 2025
- Ginger Vieira
Tandem & Abbott Partner to Develop Technology that Measures Glucose & Ketones
Healthcare
- May 21, 2025
- Ginger Vieira
Breakthrough T1D Submits Application to Make T1D Screening Routine Care
Insulin
- May 10, 2025
- Ginger Vieira
Inhaled Insulin in Kids? Clinical Trial Update
News
- April 29, 2025
- Ginger Vieira
Eversense Announces Insulin Pump Partnership
GLP-1
- April 6, 2025
- Ginger Vieira
Eli Lilly Studying Tirzepatide in People with Type 1 Diabetes
News
- March 28, 2025
- Ginger Vieira
Vertex Announces the End of VX-264 Due to Disappointing Results
Insulin
- March 11, 2025
- Ginger Vieira
20 Percent Reduction in Post-Meal Blood Sugar
News
- February 15, 2025
- Ginger Vieira
Diamyd Receives FDA Fast Track for Insulin-Protecting Therapy
Search on blog
Post List
-
Cancer Drug Triggers Insulin Production in T1D
January 3, 2024 By Ginger Vieira -
Vertex VX-880 and VX-264 Clinical Trial Updates
September 25, 2024 By Ginger Vieira -
20 Percent Reduction in Post-Meal Blood Sugar
March 11, 2025 By Ginger Vieira
Categories
TAG CLOUD
autoantibodies
Blog
Business
cgm
cure research
diabetes
diabetes research
diabetes technology
Digital
eversense
gene editing
genetic risk
glp-1
heart health
hypoimmune islet cells
immunomodulator
immunosuppression
inhaled insulin
insulin
insulin research
ketones
Mental Health
mounjaro
obesity
ozempic
research
risk of type 1 diabetes
sana biotechnology
screening
semaglutide
senseonics
sequel medtech
T1D genetics
t1d risk
Tech
tirzepatide
twiist
type 1 diabetes
type 1 diabetes diagnosis
type 1 diabetes prevention
type 2 diabetes
vertex
wegovy
weight loss
Wordpress
